Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report

Abdullah Muqrin Al Muqrin,1 Abdulaziz A Alghamdi,1 Ziad M AlShaalan2 1Dermatology, Prince Mohammed Medical City, Skaka, AlJouf, Saudi Arabia; 2Department of Internal Medicine, College of Medicine, Jouf University, Skakak, AlJouf, Saudi ArabiaCorrespondence: Abdullah Muqrin Al Muqrin, Dermatology, Pr...

Full description

Bibliographic Details
Main Authors: Al Muqrin AM, Alghamdi AA, AlShaalan ZM
Format: Article
Language:English
Published: Dove Medical Press 2022-10-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
Online Access:https://www.dovepress.com/rapid-response-of-palmoplantar-psoriasis-to-risankizumab-a-case-report-peer-reviewed-fulltext-article-CCID
_version_ 1817980601546833920
author Al Muqrin AM
Alghamdi AA
AlShaalan ZM
author_facet Al Muqrin AM
Alghamdi AA
AlShaalan ZM
author_sort Al Muqrin AM
collection DOAJ
description Abdullah Muqrin Al Muqrin,1 Abdulaziz A Alghamdi,1 Ziad M AlShaalan2 1Dermatology, Prince Mohammed Medical City, Skaka, AlJouf, Saudi Arabia; 2Department of Internal Medicine, College of Medicine, Jouf University, Skakak, AlJouf, Saudi ArabiaCorrespondence: Abdullah Muqrin Al Muqrin, Dermatology, Prince Mohammed Medical City, Skaka City, 72345, AlJouf, Saudi Arabia, Tel +96654777446, Email Abdullah.mq4@outlook.comAbstract: Palmoplantar psoriasis, a clinical variant of plaque psoriasis, has a significant impact by causing deterioration in the social and functional aspects of patients’ lives. Numerous therapeutic interventions are available for palmoplantar psoriasis. Although emerging biological agents have had an enormous positive impact on chronic plaque psoriasis, studies assessing their effectiveness in the palmoplantar phenotype are limited in the literature. We therefore present a case report of a patient with a 10-year history of palmoplantar psoriasis, which has significantly impacted her occupational life. She was treated with Risankizumab, showing a significant and rapid improvement in her symptoms. We believe that Risankizumab could be one of the most effective therapeutic interventions in the clinical context where rapid clearance of palmoplantar psoriasis is required.Keywords: psoriasis, Risankizumab, palmoplantar, rapid onset, biologic, biological agent
first_indexed 2024-04-13T22:55:31Z
format Article
id doaj.art-12302e83e59a4a54b07cd04d16210c86
institution Directory Open Access Journal
issn 1178-7015
language English
last_indexed 2024-04-13T22:55:31Z
publishDate 2022-10-01
publisher Dove Medical Press
record_format Article
series Clinical, Cosmetic and Investigational Dermatology
spelling doaj.art-12302e83e59a4a54b07cd04d16210c862022-12-22T02:26:02ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152022-10-01Volume 152129213278723Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case ReportAl Muqrin AMAlghamdi AAAlShaalan ZMAbdullah Muqrin Al Muqrin,1 Abdulaziz A Alghamdi,1 Ziad M AlShaalan2 1Dermatology, Prince Mohammed Medical City, Skaka, AlJouf, Saudi Arabia; 2Department of Internal Medicine, College of Medicine, Jouf University, Skakak, AlJouf, Saudi ArabiaCorrespondence: Abdullah Muqrin Al Muqrin, Dermatology, Prince Mohammed Medical City, Skaka City, 72345, AlJouf, Saudi Arabia, Tel +96654777446, Email Abdullah.mq4@outlook.comAbstract: Palmoplantar psoriasis, a clinical variant of plaque psoriasis, has a significant impact by causing deterioration in the social and functional aspects of patients’ lives. Numerous therapeutic interventions are available for palmoplantar psoriasis. Although emerging biological agents have had an enormous positive impact on chronic plaque psoriasis, studies assessing their effectiveness in the palmoplantar phenotype are limited in the literature. We therefore present a case report of a patient with a 10-year history of palmoplantar psoriasis, which has significantly impacted her occupational life. She was treated with Risankizumab, showing a significant and rapid improvement in her symptoms. We believe that Risankizumab could be one of the most effective therapeutic interventions in the clinical context where rapid clearance of palmoplantar psoriasis is required.Keywords: psoriasis, Risankizumab, palmoplantar, rapid onset, biologic, biological agenthttps://www.dovepress.com/rapid-response-of-palmoplantar-psoriasis-to-risankizumab-a-case-report-peer-reviewed-fulltext-article-CCIDpsoriasisrisankizumabpalmoplantarrapid onsetbiologicbiological agent.
spellingShingle Al Muqrin AM
Alghamdi AA
AlShaalan ZM
Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
Clinical, Cosmetic and Investigational Dermatology
psoriasis
risankizumab
palmoplantar
rapid onset
biologic
biological agent.
title Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
title_full Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
title_fullStr Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
title_full_unstemmed Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
title_short Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
title_sort rapid response of palmoplantar psoriasis to risankizumab a case report
topic psoriasis
risankizumab
palmoplantar
rapid onset
biologic
biological agent.
url https://www.dovepress.com/rapid-response-of-palmoplantar-psoriasis-to-risankizumab-a-case-report-peer-reviewed-fulltext-article-CCID
work_keys_str_mv AT almuqrinam rapidresponseofpalmoplantarpsoriasistorisankizumabacasereport
AT alghamdiaa rapidresponseofpalmoplantarpsoriasistorisankizumabacasereport
AT alshaalanzm rapidresponseofpalmoplantarpsoriasistorisankizumabacasereport